Drug – bio-affecting and body treating compositions – Identification or warning feature – Taste or smell or chemical irritation to the eye – nose – or...
Patent
1976-06-01
1977-01-18
Wolk, Morris O.
Drug, bio-affecting and body treating compositions
Identification or warning feature
Taste or smell or chemical irritation to the eye, nose, or...
23230B, 23253TP, 252408, G01N 3102, G01N 3316
Patent
active
040039889
ABSTRACT:
Direct agglutination reagent for pregnancy testing which comprises the use of suspensions of polystyrene latex particles sensitized with a globulin fraction of anti-serum to human chorionic gonadotropin (HCG). When mixed with urine or blood serum samples containing HCG, this reagent agglutinates indicating a positive test for pregnancy.
REFERENCES:
patent: 3088875 (1963-05-01), Fisk
patent: 3171783 (1965-03-01), Fisk
patent: 3234096 (1966-02-01), Pollack
patent: 3236732 (1966-02-01), Arquilla
patent: 3309275 (1967-03-01), Treacy
patent: 3551555 (1970-12-01), Schuurs
patent: 3565987 (1971-02-01), Schuurs
patent: 3862302 (1975-01-01), Price
Hoff Gail
Prevorsek Metka
Chow Frank S.
Graddis Albert H.
Marantz Sidney
Warner-Lambert & Company
Wolk Morris O.
LandOfFree
Direct agglutination test for pregnancy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Direct agglutination test for pregnancy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Direct agglutination test for pregnancy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-72732